Cogprints

Selecting Dual Chamber or Single Chamber Implantable Defibrillators: What is the Golden Rule?

Santini, Massimo and Ricci, Renato (2003) Selecting Dual Chamber or Single Chamber Implantable Defibrillators: What is the Golden Rule? [Journal (Paginated)]

Full text available as:

[img]HTML
43Kb

Abstract

During the last years, the implantation rate of dual chamber defibrillators (ICD) significantly increased worldwide. In 1999, the proportion of dual chamber ICD implants reached 30% in Europe and 50% in U.S.A.1. According to manufacturer data, in Italy, the ratio between implanted single chamber and dual chamber units decreased from 1.97 in 1999 to 1.86 in 2000 and 1.50 in 2001. Technological progress, demonstration of reliability and clinical efficacy of the new devices, combined with their smaller size, contributed to their wide acceptance. Nowadays, the matter to be debated is if all the patients in whom the atrium can be sensed and paced should receive a dual chamber ICD or if device selection should be individually evaluated according to different clinical profiles. As a matter of fact, criteria to identify the patients who may benefit more from dual chamber ICD have not been already defined. The theoretical advantages of dual chamber ICD include: improved discrimination between supraventricular and ventricular tachycardias, optimal treatment of symptomatic bradycardias (pre-existing, drug-induced or late developing), hemodynamic and antiarrhythmic benefits.

Item Type:Journal (Paginated)
Keywords:defibrillator, inappropriate shock, atrial fibrillation, heart failure, ventricular dysynchrony
Subjects:JOURNALS > Indian Pacing and Electrophysiology Journal
ID Code:4252
Deposited By:Indian Pacing and Electrophysiology, Journal
Deposited On:20 Apr 2005
Last Modified:11 Mar 2011 08:55

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

1. Jung W and Luderitz B: Should all candidates for ICD therapy receive a dual chamber system? J Int Card Electrophysiol 1999;3:203-206.

2. Barold HS, Newby KH, Tomassoni G, Kearney M, Brandon J, Natale A: Prospective evaluation of new and old criteria to discriminate between supraventricular and ventricular tachycardia in implantable defibrillators. Pacing Clin Electrophysiol 1998;21:1347-55.

3. Swerdlow CD, Chen PS, Kass RM, Allard JR, Peter CT: Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter defibrillator. J Am Coll Cardiol 1994;23:1342-55.

4. Schaumann A, von zur Muhlen F, Gonska BD, Kreuzer H: Enhanced detection criteria in implantable cardioverter-defibrillators to avoid inappropriate therapy. Am J Cardiol 1996;78(5A):42-50.

5. Brugada J: Is inappropriate therapy a resolved issue with current implantable cardioverter defibrillators? Am J Cardiol 1999;83:40D-44D.

6. Neuzner J, Pitschner HF, Schlepper: Programmable VT detection enhancements in implantable cardioverter defibrillator therapy. Pacing Clin Electrophysiol 1995;18:539-47.

7. Sinha AM, Stellbrink C, Karla D, Hahn A, Hanrath P: Discrimination of ventricular and supraventricular tachycardias with a new detection algorithm in a dual chamber ICD. MZV Verlag 2000;20;201-7.

8. Sadoul N, Jung W, Jordaens L, et al: Diagnostic performance of a dual-chamber cardioverter defibrillator programmed with nominal settings: a European prospective study. J Cardiovasc Electrophysiol. 2002;13:25-32.

9. Wilkoff BL, Kuhlkamp V, Volosin K, et al: Critical analysis of dual chamber implantable cardioverter defibrillator arrhyhtmia detection. Results and technical considerations. Circulation 2001;103:381-386.

10. Korte T, Jung W, Wolpert C, et al: A new classification algorithm for discrimination of ventricular from supraventricular tachycardia in a dual chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 1998;9:70-3.

11. Osswald S, Cron TA, Sterns L, Alt E, Stotts L, Coenen M: New ICD technologies: first clinical experience with dual chamber sensing for differentiation of supraventricular tachyarrhythmias. Pacing Clin Electrophysiol 1998;21:292-5.

12. Boriani G, Biffi M, Dall’Acqua A, et al: Rhythm discrimination based on rate branch and morphology discrimination algorithm to improve the diagnostic performance in a dual chamber implantable cardioverter defibrillator. Eur Heart J 2001;22 (Abstract Suppl.):178.

13. Hintringer F, Schwarzacher S, Eibl G, Pachinger O: Inappropriate detection of supraventricular arrhythmias by implantable dual chamber defibrillators: a comparison of four different algorithms. Pacing Clin Electrophysiol 2001;24:835-841.

14. Deisenhofer I, Kolb C, Ndrepepa G, et al: Do current dual chamber cardioverter defibrillators have advantages over conventional sigle chamber cardioverter defibrillator in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001;12:134-42.

15. Frohlig G, Helwani Z, Kusch O, Berg M, Schieffer H: Bipolar ventricular far-field signals in the atrium. Pacing Clin Electrophysiol 1999;22:1604-13.

16. Weretka S, Becker R, Hilbel T, et al: Far-field R wave oversensing in a dual chamber arrhythmia management device: predisposing factors and practical implications. Pacing Clin Electrophysiol 2001;24:1240-6.

17. Hesselson AB, Parsonnet V, Bernstein AD, Bonavita GJ: Deleterious effect of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: The hidden benefits of dual-chamber pacing. J Am Coll Cardiol 1992;19:1542-1549.

18. Frielingsdorf J, Gerber AE, Dur P, Vuilliomenet A, Bertel O: Importance of an individually programmed atrioventricular delay at rest and on work capacity in patients with dual chamber pacemakers. Pacing Clin Electrophysiol 1994;17:37-45.

19. Frielingsdorf J, Deseo T, Gerber AE, Bertel O: A comparison of quality-of-life in patients with dual chamber pacemakers and individually programmed atrio-ventricular delays. Pacing Clin Electrophysiol 1996;19:1147-1154.

20. Harper GR, Pina IL, Kutalek SP: Intrinsic conduction maximizes cardiopulmonary performance in patients with dual chamber pacemakers. Pacing Clin Electrophysiol 1991;14:1787-1791.

21. Ansalone G, Trambaiolo P, Giorda G, Giannantoni P, Ricci R, Santini M: Multisite stimulation in refractory heart failure. G Ital Cardiol 1999;29:451-459.

22. Ansalone G, Giannantoni P, Ricci R, et al: Doppler myocardial imaging in patients with heart failure receiving biventricular pacing treatment. Am Heart J 2001;142:881-896.

23. Moss AJ, Hall WJ, Cannom DS, et al: Improved survival with an implanted defibrillator in patients with prior myocardial infarction, low ejection fraction and asymptomatic non-sustained ventricular tachycardia. N Engl J Med 1996;335:1933-40.

24. The AVID investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.

25. Wilkoff BL, Cook JR, Epstein AE, et al. The DAVID Trial Investigators: Dual chamber pacing or ventricular bacup pacing in patients with an implantable defibrillator. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-23.

26. Schmitt C, Montero M, Melichercik J: Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. Pacing Clin Electrophysiol 1998;17:295-302.

27. Grimm W, Flores BF, Marchlinski FE. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators.

Pacing Clin Electrophysiol. 1992;15:1667-73.

28. Marchlinski FE, Callans DJ, Gottlieb CD, Schwartzman D, Preminger M: Benefits and lessons learned from stored electrogram information in implantable defibrillators. J Cardiovasc Electrophysiol. 1995;6:832-51.

29. Pinski SL, Yao Q, Epstein AE, et al: Determinants of outcome in patients with sustained ventricular tachyarrhythmias: the antiarrhythmic versus implantable defibrillators (AVID) study registry. Am Heart J 2000;139:804-813.

30. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D’Agostino RB: Impact of atrial fibrillation on mortality, stroke and medical costs. Arch Intern Med 1998;158:229-234.

31. Ricci R, Pignalberi C, Disertori M, et al: Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J 2002;23:1471-1479.

32. Schoels W, Swerdlow CD, Jung W, Stein KM, Seidl KH, Haffajee CJ, for the Worldwide Jewel AF Investigators: Worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator system. J Cardiovasc Electrophysiol 2001;12:521-528.

33. Friedman PA, Dijkman B, Warman EN, et al, for the Worldwide Jewel AF Investigators: Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation. 2001;104:1023-1028.

34. Quesada A, Almendral J, Arribas F, et al on behalf of DATAS investigators. The DATAS rationale and design: A controlled, randomized trial assessing the clinical benefit of the dual chamber (DDED) defibrillator (in press).

35. Moss AJ, Zareba W, Jackson Hall W, et al: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.

36. Cazeau S, Leclerq C, Lavergne T, et al: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001:344:873-880.

37. Abraham WT, Fisher WG, Smith AL, et al: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53

Metadata

Repository Staff Only: item control page